"El proyecto pretende empoderar a los pacientes y supervivientes de cáncer, así como a su entorno, convirtiéndolos en protagonistas de su salud mediante una atención integral que responda realmente a sus necesidades a largo plazo a todos los niveles. El objetivo principal es mejorar su calidad de vida y favorecer una adaptación personal, familiar, social y laboral. Esto ha supuesto un cambio de mentalidad institucional hacia una atención centrada en el paciente más integral que engloba a su entorno partiendo de las propias experiencias de los pacientes con sus preferencias. Además, se pretende mejorar de forma continua en base al conocimiento generado."

During the past decade, Hospital Universitario de Fuenlabrada; Servicio de Oncologia conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario de Fuenlabrada; Servicio de Oncologia" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "SOLTI Breast Cancer Research Group" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator and "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario de Fuenlabrada; Servicio de Oncologia" are "Breast Cancer" (2 trials), "Triple Negative Breast Cancer" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Hospital Universitario de Fuenlabrada; Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Hospital Universitario de Fuenlabrada; Servicio de Oncologia" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (3 trials), "Placebo" (2 trials), "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials) and "Atezolizumab Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario de Fuenlabrada; Servicio de Oncologia" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Universitario de Fuenlabrada; Servicio de Oncologia". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Universitario de Fuenlabrada; Servicio de Oncologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario de Fuenlabrada; Servicio de Oncologia, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".